الصفحة الرئيسية>>Signaling Pathways>> PROTAC>>PROTAC Sirt2 Degrader-1

PROTAC Sirt2 Degrader-1

رقم الكتالوجGC33418

PROTAC Sirt2 Degrader-1 عبارة عن PROTAC مقره SirReal ، يعمل كمطهر Sirt2 ، يتألف من مثبط Sirt2 قوي للغاية وانتقائي للنمط المتماثل ، ورابط ، ورابط Cereblon حقيقي لـ E3 ubiquitin ligaseيُظهر PROTAC Sirt2 Degrader-1 IC50 بمقدار 0.25 ميكرومتر لـ Sirt2 ، مع عدم وجود تأثير على Sirt1 / Sirt3 (IC50s> 100 ميكرومتر)

Products are for research use only. Not for human use. We do not sell to patients.

PROTAC Sirt2 Degrader-1 التركيب الكيميائي

Cas No.: 2098487-75-1

الحجم السعر المخزون الكميّة
5mg
1011٫00
متوفر
10mg
1563٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PROTAC Sirt2 Degrader-1 is a SirReal-based PROTAC, acts as a Sirt2 degrader, composed of a highly potent and isotype-selective Sirt2 inhibitor, a linker and thalidomide, a bona fide cereblon ligand for E3 ubiquitin ligase. PROTAC Sirt2 Degrader-1 shows an IC50 of 0.25 μM for Sirt2, with no effect on Sirt1/Sirt3 (IC50s > 100 μM)[1].

PROTAC Sirt2 Degrader-1 (Compound 12; 10 µM, 1-6 hours) induces Sirt2 degradation in HeLa cells[1].|| Western Blot Analysis[1]||Cell Line:|HeLa cells|Concentration:|10 µM|Incubation Time:|1-6 hours|Result:|Caused Sirt2 degradation, but showed no effect on Sirt1 levels.

[1]. Schiedel M, et al. Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals). J Med Chem. 2018 Jan 25;61(2):482-491.

مراجعات

Review for PROTAC Sirt2 Degrader-1

Average Rating: 5 ★★★★★ (Based on Reviews and 38 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PROTAC Sirt2 Degrader-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.